KRTL BioTech

Tech investors: No broad lessons seen in WeWork valuation drama

Tech investors: No broad lessons seen in WeWork valuation drama

Two top technology investors cautioned against drawing broadconclusions about the valuation of private companies from questions swirling around U.S. office-sharing startup WeWork.